NCT07047820View on ClinicalTrials.gov

A Study to Learn More About How Zuranolone Affects Postpartum Depression Symptoms in Participants Who Took it Within 1 Year After The End of Their Pregnancy

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

August 24, 2026

Study Completion Date

August 24, 2026

Conditions
Depression, Postpartum
Interventions
DRUG

Zuranolone

Administered as specified in the treatment arm

Trial Locations (1)

02895

RECRUITING

CVS Health, Woonsocket

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY

NCT07047820 - A Study to Learn More About How Zuranolone Affects Postpartum Depression Symptoms in Participants Who Took it Within 1 Year After The End of Their Pregnancy | Biotech Hunter | Biotech Hunter